PLoS Medicine (Jan 2017)

Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach.

  • Michael M Mendelson,
  • Riccardo E Marioni,
  • Roby Joehanes,
  • Chunyu Liu,
  • Åsa K Hedman,
  • Stella Aslibekyan,
  • Ellen W Demerath,
  • Weihua Guan,
  • Degui Zhi,
  • Chen Yao,
  • Tianxiao Huan,
  • Christine Willinger,
  • Brian Chen,
  • Paul Courchesne,
  • Michael Multhaup,
  • Marguerite R Irvin,
  • Ariella Cohain,
  • Eric E Schadt,
  • Megan L Grove,
  • Jan Bressler,
  • Kari North,
  • Johan Sundström,
  • Stefan Gustafsson,
  • Sonia Shah,
  • Allan F McRae,
  • Sarah E Harris,
  • Jude Gibson,
  • Paul Redmond,
  • Janie Corley,
  • Lee Murphy,
  • John M Starr,
  • Erica Kleinbrink,
  • Leonard Lipovich,
  • Peter M Visscher,
  • Naomi R Wray,
  • Ronald M Krauss,
  • Daniele Fallin,
  • Andrew Feinberg,
  • Devin M Absher,
  • Myriam Fornage,
  • James S Pankow,
  • Lars Lind,
  • Caroline Fox,
  • Erik Ingelsson,
  • Donna K Arnett,
  • Eric Boerwinkle,
  • Liming Liang,
  • Daniel Levy,
  • Ian J Deary

DOI
https://doi.org/10.1371/journal.pmed.1002215
Journal volume & issue
Vol. 14, no. 1
p. e1002215

Abstract

Read online

BackgroundThe link between DNA methylation, obesity, and adiposity-related diseases in the general population remains uncertain.Methods and findingsWe conducted an association study of body mass index (BMI) and differential methylation for over 400,000 CpGs assayed by microarray in whole-blood-derived DNA from 3,743 participants in the Framingham Heart Study and the Lothian Birth Cohorts, with independent replication in three external cohorts of 4,055 participants. We examined variations in whole blood gene expression and conducted Mendelian randomization analyses to investigate the functional and clinical relevance of the findings. We identified novel and previously reported BMI-related differential methylation at 83 CpGs that replicated across cohorts; BMI-related differential methylation was associated with concurrent changes in the expression of genes in lipid metabolism pathways. Genetic instrumental variable analysis of alterations in methylation at one of the 83 replicated CpGs, cg11024682 (intronic to sterol regulatory element binding transcription factor 1 [SREBF1]), demonstrated links to BMI, adiposity-related traits, and coronary artery disease. Independent genetic instruments for expression of SREBF1 supported the findings linking methylation to adiposity and cardiometabolic disease. Methylation at a substantial proportion (16 of 83) of the identified loci was found to be secondary to differences in BMI. However, the cross-sectional nature of the data limits definitive causal determination.ConclusionsWe present robust associations of BMI with differential DNA methylation at numerous loci in blood cells. BMI-related DNA methylation and gene expression provide mechanistic insights into the relationship between DNA methylation, obesity, and adiposity-related diseases.